Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Key takeaway
Capricor Therapeutics faces a class action lawsuit for failing to disclose material information.
- Step 1 · The triggerCapricor Therapeutics fails to disclose material information, triggering a class action lawsuit.
- Step 2 · Knock-onThe lawsuit leads to a significant drop in Capricor's stock price, affecting investor confidence.
- Step 3 · Reaches youKahn Swick & Foti, LLC benefits financially from representing investors in the lawsuit.
The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.
Source: PR Newswire
See what today’s news does to your business. Atri by Branch² — Early-warning intelligence for SMEsThis is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.